Clinical Trial Update: Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluated Tenofovir for hepatitis B reactivation presenting as acute-on-chronic liver failure, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• On Chronic Liver Failure

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Govind Ballabh Pant Hospital | Conditions: Acute on Chronic Liver Failure, Hepatitis B | Phase 4 | Status: COMPLETED